Kiniksa Pharmaceuticals International News

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Delivers Shareholders Stellar 23% CAGR Over 5 Years, Surging 4.7% in the Last Week Alone

Simply Wall StSep 17 10:12 ET

Kiniksa Draws Buy at Jefferies on Potential Blockbuster Status for Lead Drug

Seeking AlphaSep 13 11:20 ET

Jefferies Initiates Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Announces Target Price $40

Moomoo NewsSep 13 05:33 ET · Ratings

J.P. Morgan Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $39

Moomoo NewsSep 12 08:32 ET · Ratings

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

newsfilter.ioAug 28 16:01 ET

Roth MKM Says Small-Cap Value Reaches Key Technical Support, Lists 14 "Bullish" Stocks

Seeking AlphaAug 12 11:34 ET

New Strong Buy Stocks for August 1st

Zacks Aug 1 06:25 ET

Express News | Kiniksa Pharmaceuticals Ltd : JP Morgan Raises Target Price to $38 From $30

ReutersAug 1 01:34 ET

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $578,966, According to a Recent SEC Filing

MT NewswiresJul 26 08:34 ET

Kiniksa Pharmaceuticals International(KNSA.US) Officer Sells US$3.49 Million in Common Stock

Moomoo NewsJul 25 16:36 ET

Kiniksa Pharmaceuticals International | 10-Q: Q2 2024 Earnings Report

SECJul 25 16:16 ET · Announcements

Kiniksa Pharmaceuticals International And Two More Firms Possibly Priced Below Market Value Estimates

Yahoo FinanceJul 24 09:07 ET

There's No Escaping Kiniksa Pharmaceuticals International, Plc's (NASDAQ:KNSA) Muted Revenues Despite A 41% Share Price Rise

Simply Wall StJul 24 08:47 ET

Evercore Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsJul 24 08:33 ET · Ratings

Express News | Kiniksa Pharmaceuticals Ltd. : Wells Fargo Raises Target Price to $35 From $34

ReutersJul 24 06:48 ET

Wells Fargo Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $35

Moomoo NewsJul 24 05:32 ET · Ratings

Earnings Call Summary | Kiniksa Pharmaceuticals International(KNSA.US) Q2 2024 Earnings Conference

moomoo AIJul 24 05:11 ET · Conference Call

Form 144 | Kiniksa Pharmaceuticals International(KNSA.US) Officer Proposes to Sell 3.49 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 23, $Kiniksa Pharmaceuticals International(KNSA.US)$ Officer Patel Sanj K intends to sell 136.12K shares of its common stock on Jul 23, with a total market value of

Moomoo NewsJul 23 16:41 ET

Kiniksa Pharmaceuticals International, Plc (KNSA) Q2 2024 Earnings Call Transcript

Earnings Call TranscriptsJul 23 13:30 ET

Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $34

BenzingaJul 23 12:55 ET · Ratings